Bausch Health Companies Inc.

In News

Bausch Health (BHC) Jumps 8.5% as Exec Hikes Stake; Subsidiaries Raise Over $3-Billion Fresh Funds - Yahoo Finance

Yahoo Finance - Jun 14, 2025

First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan

Stock Titan - Jul 07, 2025

August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq

Nasdaq - Jul 03, 2025

Billionaire Carl Icahn builds 34% economic interest in Bausch Health - Reuters

Reuters - Apr 22, 2025

Bausch Health to Announce Second Quarter 2025 Results on July 30 - ACCESS Newswire

ACCESS Newswire - Jul 02, 2025

Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - New Castle News

New Castle News - Jul 07, 2025

Bausch Health: Repricing Potential Driven By Deleveraging (NYSE:BHC) - Seeking Alpha

Seeking Alpha - Jun 16, 2025

Bausch Health Cancels Plans to Sell B+L ... For Now - Medical Device and Diagnostic industry

Medical Device and Diagnostic industry - Feb 10, 2025

Bausch Health Signs New Board Agreements - TipRanks

TipRanks - May 20, 2025

With 51% institutional ownership, Bausch Health Companies Inc. (NYSE:BHC) is a favorite amongst the big guns - Yahoo Finance

Yahoo Finance - May 29, 2025

Private Equity Buyout Rejected: Inside Bausch Health's Strategic Decision on Bausch + Lomb - Stock Titan

Stock Titan - Feb 06, 2025

Is Bausch Health Companies Inc. (BHC) the Best Canadian Penny Stock to Invest in Now? - Yahoo Finance

Yahoo Finance - Apr 23, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.